DOSIERPLÄNE

European patent · EP3359555 · In force

Register entry

Publication number
EP3359555
Application number
EP16854499
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 7, 2016
Published
Aug 15, 2018
Granted
Dec 20, 2023
Protection ends at the latest
Oct 6, 2036
Next annual fee due
Oct 31, 2026
IPC classes
C07K 7/06 (2006.01)
C07K 7/50 (2006.01)
C07K 7/64 (2006.01)
C07K 14/47 (2006.01)
A61K 38/04 (2006.01)
A61K 38/12 (2006.01)
Priority
US 201562238529 P 07.10.2015
US 201662372259 P 08.08.2016
PCT application
PCT/US2016/056144 07.10.2016
PCT publication
WO2017/062879 13.04.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  3. Oct 30, 2024

    Change

    Published in Swissreg on 30.10.2024

  4. Mar 19, 2024

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach, 8027 Zürich

    Published in Swissreg on 19.03.2024

  5. Dec 20, 2023

    Granted

    Published in Swissreg on 20.12.2023

Parties

Holder

Apellis Pharmaceuticals, Inc.

100 5th Avenue, Waltham, MA 02451, US

Agent

Isler & Pedrazzini AG

Postfach, 8027 Zürich

Inventor

DESCHATELETS, Pascal

Prospect, Kentucky 40059, US

GROSSI, Federico

Fisherville, Kentucky 40023, US

FRANCOIS, Cedric

Prospect, Kentucky 40059, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.